AGRX - Agile Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate-0.11-0.11-0.43-0.45
Low Estimate-0.13-0.14-0.52-0.85
High Estimate-0.09-0.08-0.340.11
Year Ago EPS-0.16-0.11-0.58-0.43
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. EstimateN/AN/AN/A18.44M
Low EstimateN/AN/AN/A5.02M
High EstimateN/AN/AN/A35.4M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.17-0.15-0.15-0.1
EPS Actual-0.16-0.11-0.11-0.13
Difference0.010.040.04-0.03
Surprise %5.90%26.70%26.70%-30.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.11-0.11-0.43-0.45
7 Days Ago-0.11-0.11-0.43-0.45
30 Days Ago-0.11-0.11-0.43-0.43
60 Days Ago-0.09-0.09-0.36-0.41
90 Days Ago-0.09-0.09-0.35-0.53
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/A11N/A
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesAGRXIndustrySectorS&P 500
Current Qtr.31.20%N/AN/A0.02
Next Qtr.N/AN/AN/A0.04
Current Year25.90%N/AN/A0.05
Next Year-4.70%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A